• Explore /
  • Poster
  • / Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07).

Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07).

Abstract Poster

Authors

Daniel Helbling

Daniel Helbling

Onkozentrum Zurich, Zurich, Switzerland

Daniel Helbling , Gyorgy Bodoky , Oliver Gautschi , Stefanie Hayoz , Fred Bosman , Axel Madlung , Beat Gloor , Roger Burkhard , Daniel Rauch , Ralph C. Winterhalder , Piercarlo Saletti , Lukas Widmer , Markus M. Borner , Daniela Baertschi , Pu Yan , Dieter Koeberle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00814619

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 762)

DOI

10.1200/jco.2015.33.3_suppl.762

Abstract #

762

Poster Bd #

E52

Abstract Disclosures

Similar Posters

First Author: D. Helbling

First Author: Simon Gollins

First Author: Sara Pini

First Author: D. Koeberle